Northwestern Mutual Wealth Management Co. Buys 4,044,638 Shares of BlackRock Health Sciences Trust $BME

Northwestern Mutual Wealth Management Co. boosted its stake in BlackRock Health Sciences Trust (NYSE:BMEFree Report) by 285,436.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,046,055 shares of the company’s stock after purchasing an additional 4,044,638 shares during the period. Northwestern Mutual Wealth Management Co.’s holdings in BlackRock Health Sciences Trust were worth $166,414,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in BME. Geneos Wealth Management Inc. lifted its stake in BlackRock Health Sciences Trust by 200.0% in the 2nd quarter. Geneos Wealth Management Inc. now owns 4,899 shares of the company’s stock valued at $179,000 after purchasing an additional 3,266 shares during the last quarter. Truist Financial Corp bought a new position in BlackRock Health Sciences Trust in the 3rd quarter valued at approximately $205,000. Envestnet Asset Management Inc. bought a new position in BlackRock Health Sciences Trust in the 3rd quarter valued at approximately $209,000. Oppenheimer & Co. Inc. lifted its stake in BlackRock Health Sciences Trust by 5.9% in the 3rd quarter. Oppenheimer & Co. Inc. now owns 6,715 shares of the company’s stock valued at $250,000 after purchasing an additional 373 shares during the last quarter. Finally, Stratos Wealth Partners LTD. lifted its stake in BlackRock Health Sciences Trust by 11.5% in the 3rd quarter. Stratos Wealth Partners LTD. now owns 7,673 shares of the company’s stock valued at $286,000 after purchasing an additional 790 shares during the last quarter.

BlackRock Health Sciences Trust Price Performance

Shares of NYSE:BME opened at $38.80 on Friday. The firm has a 50 day simple moving average of $39.39 and a 200 day simple moving average of $40.47. BlackRock Health Sciences Trust has a one year low of $35.03 and a one year high of $42.74.

BlackRock Health Sciences Trust Announces Dividend

The firm also recently declared a monthly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Monday, June 15th will be given a $0.2621 dividend. This represents a c) annualized dividend and a yield of 8.1%. The ex-dividend date is Monday, June 15th.

BlackRock Health Sciences Trust Profile

(Free Report)

BlackRock Health Sciences Trust (NYSE: BME) is a closed-end management investment company that seeks long-term total return through a combination of dividend income and capital appreciation. Managed by BlackRock Fund Advisors, the trust invests primarily in the equity securities of domestic and international issuers engaged in the health sciences sector. The portfolio typically includes common stocks, corporate bonds and convertible securities of companies involved in biotechnology, pharmaceuticals, medical devices and healthcare services.

Further Reading

Want to see what other hedge funds are holding BME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Health Sciences Trust (NYSE:BMEFree Report).

Institutional Ownership by Quarter for BlackRock Health Sciences Trust (NYSE:BME)

Receive News & Ratings for BlackRock Health Sciences Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Trust and related companies with MarketBeat.com's FREE daily email newsletter.